{
    "organizations": [],
    "uuid": "11ae588dc4638b4021c9b6b817c11acf6f47e25d",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-luye-pharma-group-acquires-astraze/brief-luye-pharma-group-acquires-astrazenecas-rights-relating-to-seroquel-and-seroquel-xr-idUSFWN1SE0T1",
    "ord_in_thread": 0,
    "title": "Luye Pharma Group Acquires Astrazeneca's Rights Relating To Seroquel And Seroquel XR",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 7 (Reuters) - Luye Pharma Group Ltd:\n* ANNOUNCES ACQUISITION OF ASTRAZENECAâ€™S RIGHTS RELATING TO SEROQUEL AND SEROQUEL XR IN CHINA AND IN OTHER TERRITORIES\n* PURCHASE PRICE FOR TRANSFERRED ASSETS AND LICENSED ASSETS IS IN AGGREGATE SUM OF US$546 MILLION\n* ASTRAZENECA TO TRANSFER ASSETS & GRANT A LICENCE FOR ASSETS TO UNIT IN TERRITORIES INCLUDING CHINA, BRAZIL, AMONG OTHERS Source text for Eikon:\nOur ",
    "published": "2018-05-07T21:08:00.000+03:00",
    "crawled": "2018-05-08T16:21:11.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "luye",
        "pharma",
        "group",
        "ltd",
        "announces",
        "acquisition",
        "astrazeneca",
        "right",
        "relating",
        "seroquel",
        "seroquel",
        "xr",
        "china",
        "territory",
        "purchase",
        "price",
        "transferred",
        "asset",
        "licensed",
        "asset",
        "aggregate",
        "sum",
        "u",
        "million",
        "astrazeneca",
        "transfer",
        "asset",
        "grant",
        "licence",
        "asset",
        "unit",
        "territory",
        "including",
        "china",
        "brazil",
        "among",
        "others",
        "source",
        "text",
        "eikon"
    ]
}